MET and neoplasm: Because obesity leads to a critical elevation in HGF/cMET secretion in breast cancer, researchers have investigated whether a small-molecule cMET inhibitor (e.g., crizotinib) has effects on BBC tumor progression in LFD- and HFD-fed C3(1)-Tag BBC mice [102].